Crossmark

Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired

Crossref DOI link: https://doi.org/10.1186/s12935-023-02902-0

Published Online: 2023-04-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Marei, Hany E.

Hasan, Anwarul

Pozzoli, Giacomo

Cenciarelli, Carlo
Funding

Funding for this research was provided by:

Mansoura University
License Information

Text and Data Mining valid from 2023-04-10

Version of Record valid from 2023-04-10
More Information

Article History

Received: 19 January 2023

Accepted: 24 March 2023

First Online: 10 April 2023

Declarations

:

: not applicable.

: The authors declare no conflict of interests.

Document is current

Any future updates will be listed below